Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Mayo Clinic
Mayo Clinic
OHSU Knight Cancer Institute
University of Washington
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)